Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer

Diseases of the Esophagus · Published 2026-03-02 · DOI 10.1093/dote/doag036

Authors being retrieved — see the publisher record. https://doi.org/10.1093/dote/doag036

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles